NVCR vs HLIO
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
NVCR · Novocure$13.28 ▼ 1.99%
HLIO · Helios Technologies$47.44 ▼ 21.05%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- NVCR +17.8%
- HLIO -11.6%
Head to head
| Metric | NVCR | HLIO |
|---|---|---|
| Price | $13.28 | $47.44 |
| Change today | ▼ 1.99% | ▼ 21.05% |
| Market cap | $1.55B | $1.55B |
| Return, 3 months | -23.3% | -41.8% |
| Return, year to date | +2.7% | -10.9% |
| Return, 1 year | +21.6% | -12.2% |
| P/E (TTM) | – | 20.0 |
| P/B | 4.4 | 1.7 |
| P/E percentile vs own 5y | 48th | 48th |
| Dividend yield | – | 0.70% |
| Revenue growth (YoY, latest qtr) | +15.7% | +9.1% |
| Net profit growth (YoY) | +72.0% | +92.1% |
| Gross margin | 77.0% | 33.5% |
| Operating margin | -17.2% | 12.9% |
| Net margin | -16.8% | 8.0% |
| Return on equity | -35.2% | 7.7% |
| Analyst target vs. price | +60.6% | +98.8% |
| Analyst buy share | 67% | 100% |
| RSI (14) | 40 | 18 |
| 30-day volatility | 58.1% | 79.2% |
| Max drawdown, 1 year | -34.4% | -48.8% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- HLIO is the largest of the group by market value.
- NVCR has returned the most over the past year.
- NVCR is growing revenue fastest.
- HLIO keeps the most profit per dollar of sales.
- NVCR has been the calmest stock over the last 30 days.